ZBH Zimmer Biomet Corp Company Net Income

Official company branding of Zimmer Biomet Holdings Inc (ZBH)

Zimmer Biomet Holdings is optimizing profitability through precision "just-in-time" instrument delivery. The company's financial profit confirms the effectiveness of this model, where the value of 0.82 expresses the metric level. Automation of implant production minimizes errors, while a strategy of targeted robotic surgery startup acquisitions seamlessly integrates innovations into the core business portfolio.

ZBH Zimmer Net Income (07/04/2022 - 11/01/2026)

Financial and market metric breakdowns for Zimmer Biomet Corp (ZBH)

- market value and analyst target forecast:
Stock Price Zimmer Biomet Holdings, Inc.|ZBH - Price Target Chart
- market capitalization data:
Market Value Zimmer|ZBH - Enterprise Value
- book capitalization indicators:
Net Assets per Share Zimmer Biomet|ZBH - Company Net Assets|Market Capitalization to Net Assets zimmerbiomet.com|ZBH - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Zimmer Biomet Holdings|ZBH - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Zimmer|ZBH - Company Total Debt|Debt to Net Assets Ratio Zimmer|ZBH - Company Long-Term Debt|Company Current Liabilities Zimmer Biomet|Immediate Liquidity zimmerbiomet.com
- earnings and multiples data:
ZBH - Net Profit
Summary company analysis:zimmerbiomet.com (ZBH)
Signature product of zimmerbiomet.com

The scale of Zimmer Biomet Holdings operations is reflected in the price action of this instrument. The company's net income figure demonstrates the final financial result after all expenses, determining the issuer's real margin of safety. This metric measures the efficiency of converting revenue into capital, excluding operating costs. For ZBH, this confirms the resilience of demand for implants even amidst seasonal fluctuations in elective surgeries. Investors use this indicator to assess the balance between business reliability and profitability.

Main competitors

Boston Scientific Corporation Inc. (BSX) - Net Profit|Company Net Income Edwards Lifesciences|Company Net Income RMD|Net Profit PODD|Net Financial Result The Cooper Companies, Inc.|Align Technology Inc - Net Income|GMED (NuVasive) - Profit After Tax|TransMedics Group, Inc. - Net Profit|Company Net Income atecspine.com|AORT: Net Profit|Company Profit ENOV|Net Income IART|ESTA: Final Profit|Company Net Income Beta Bionics Inc (BBNX)|Net Income iradimed.com IRMD|Net Profit EMBC (Embecta)|Tandem Diabetes Care Inc (TNDM) - Company Net Income|Axogen Corp - Net Profit|SIBN (SI-BONE Medical) - Company Profit|OFIX: Net Profit|BVS - Net Financial Result|KIDS (OrthoPediatrics Corp) - Net Profit|Net Income Treace Medical Concepts Inc (TMCI)|Net Profit SRTA|Net Profit Carlsmed Medical (CARL)|Company Net Income RxSight, Inc. RXST|ClearPoint Neuro Inc. - Company Net Income|STXS: Net Income|Final Profit STIM (Neuronetics Inc.)|SGHT: Net Profit|Company Net Income Orchestra BioMed Inc. (OBIO)|Company Net Income Anika Therapeutics Inc.|NSPR - Annual Net Income|Net Income ZJYL (Jin Medical International)|Net Profit vivani.com (VANI)|Net Profit XTNT (Xtant Medical)|Net Financial Result NeuroOne Medical Technologies Corp. (NMTC)|MODD - Company Net Income|Profit After Tax MYO|Envoy Medical (COCH) - Company Net Income|Net Income Vivos Therapeutics Inc.|NVNO (enVVeno) - Net Profit|Company Net Income SINTX Technologies SINT|Company Net Income Tenon Medical, Inc. (TNON)|rewalk.com - Company Profit|Autonomix Medical - Net Income|Profit After Payment of Taxes IVF (INVO Bioscience)|BBLG: Net Income|Profit After Tax AXNX|BIOL: Net Profit|DYNT - Net Financial Result|Company Net Income Paragon 28 Inc.|Net Income INVO Bio (INVO)